F. MacCarthy

发表

Characteristics and outcomes of acute colitis diagnosed on cross-sectional imaging presenting via the emergency department in an Irish academic medical centre

J. Meaney, S. Norris, D. Kevans, 2020, Irish Journal of Medical Science (1971 -).

Impact of the inflammatory microenvironment on T-cell phenotype in the progression from reflux oesophagitis to Barrett oesophagus and oesophageal adenocarcinoma.

J. O’Sullivan, J. Reynolds, D. O'Toole, 2016, Cancer letters.

Altered T Cell Migratory Capacity in the Progression from Barrett Oesophagus to Oesophageal Adenocarcinoma

J. Reynolds, D. O'Toole, N. Gilmartin, 2019, Cancer Microenvironment.

Characterizing caspase-1 involvement during esophageal disease progression

J. O’Sullivan, J. Reynolds, E. Kay, 2020, Cancer Immunology, Immunotherapy.

Effect of cigarette smoke extract on the intestinal microenvironment of ulcerative colitis tissue

J. O’Sullivan, D. Kevans, N. Mahmud, 2020, JGH open : an open access journal of gastroenterology and hepatology.

Malignant Gastrocolic Fistula as a Late Complication of Radiation Therapy

J. Reynolds, O. Mc Cormack, D. Halpenny, 2012, Journal of Gastrointestinal Cancer.

The Mitochondrial Genes BAK1, FIS1 and SFN are Linked with Alterations in Mitochondrial Membrane Potential in Barrett’s Esophagus

J. O’Sullivan, J. Reynolds, D. O'Toole, 2018, International journal of molecular sciences.

Differential expression of mitochondrial energy metabolism profiles across the metaplasia-dysplasia-adenocarcinoma disease sequence in Barrett's oesophagus.

J. O’Sullivan, N. Lynam‐Lennon, J. Reynolds, 2014, Cancer letters.

Mucosal-Associated Invariant T Cells Display Diminished Effector Capacity in Oesophageal Adenocarcinoma

G. Besra, J. O’Sullivan, J. Reynolds, 2019, Front. Immunol..

Changes in mitochondrial stability during the progression of the Barrett’s esophagus disease sequence

J. O’Sullivan, N. Lynam‐Lennon, J. Phelan, 2016, BMC Cancer.

Real-time metabolic profiling of oesophageal tumours reveals an altered metabolic phenotype to different oxygen tensions and to treatment with Pyrazinib

J. O’Sullivan, J. Reynolds, B. Kennedy, 2020, Scientific Reports.

Colonic oncostatin M expression evaluated by immunohistochemistry and infliximab therapy outcome in corticosteroid-refractory acute severe ulcerative colitis

J. O’Sullivan, C. Ryan, A. Buckley, 2022, Intestinal research.

Golimumab effectiveness and safety in clinical practice for moderately active ulcerative colitis

B. Ryan, P. Macmathuna, A. O’Connor, 2018, European journal of gastroenterology & hepatology.

Irish data on the safety and efficacy of vedolizumab in the treatment of inflammatory bowel disease

C. O'Morain, B. Ryan, P. Singh, 2020, Scandinavian journal of gastroenterology.

Examining the connectivity between different cellular processes in the Barrett tissue microenvironment.

Osama Sharaf Eldin, J. O’Sullivan, J. Reynolds, 2016, Cancer letters.

Comparison of medium to long-term outcomes of acute severe ulcerative colitis patients receiving accelerated and standard infliximab induction

Á. Keogh, H. Mulcahy, D. Keegan, 2019, Frontline Gastroenterology.

Endoscopic excision of significant polyp and early colorectal cancer lesions

P. Bhandari, M. Rutter, S. Dolwani, 2019, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

P721 Early vedolizumab trough levels are associated with induction therapy outcome

B. Ryan, M. Healy, M. McCormack, 2020 .

P597 Effectiveness and safety of vedolizumab therapy in an ulcerative colitis cohort with significant prior anti-TNF exposure

C. O'Morain, B. Ryan, A. O’Connor, 2018 .

Comparison of risk scoring systems for critical care patients with upper gastrointestinal bleeding: predicting mortality and length of stay

N. Keating, M. Lincoln, F. MacCarthy, 2022, Anaesthesiology intensive therapy.

Changes in mitochondrial stability during the progression of the Barrett’s esophagus disease sequence

J. O’Sullivan, N. Lynam‐Lennon, J. Reynolds, 2016, BMC Cancer.